3rd World Antimicrobial Resistance Congress
Tyler Merkeley & Christopher Houchens 3rd World Antimicrobial Resistance Congress Accelerating a diverse global portfolio of 20 innovative antibacterial products towards clinical development leveraging a public private partnership model Washington, DC 14-15 Sep 2017
McDermott, Will & Emery Life Sciences Dealmaking Symposium
Tyler Merkeley, Kevin Outterson & Dennis Dixon Panel: Non-Dilutive Funding and Other Unique Capital Sources McDermott, Will & Emery Life Sciences Dealmaking Symposium Royal Sonesta Boston Cambridge, MA 4 Oct 2017
Forces Shaping the Future of Health & Healthcare
Kevin Outterson IHSIP Forces Shaping the Future of Health & Healthcare Boston, MA 16 Oct 2017
Addressing Antimicrobial Resistance: New Research and Funding Opportunities
Heather Shane BIO Investor Forum Panel: Addressing Antimicrobial Resistance: New Research and Funding Opportunities San Francisco, CA 17 Oct 2017
Re-Entering Antibacterial Discovery and Development Summit
Tyler Merkeley Re-Entering Antibacterial Discovery and Development Summit @ Omni Parker House CARB-X: What does it mean to be Powered by CARB-X? Boston, MA 18-20 Oct 2017
World Conference of Science Journalists
Kevin Outterson World Conference of Science Journalists Bridging Science and Societies San Francisco, CA 26-30 Oct 2017
2017 BioInfect Conference – State of the Nation
Tyler Merkeley BioNow 2017 BioInfect Conference - State of the Nation Cheshire, England 2 Nov 2017
Challenge Prize Center-Prize Advisory Panel Meeting
Presenter: Kevin Outterson Challenge Prize Center Prize Advisory Panel Meeting London, England 7 Nov 2017
Powered by CARB-X: How CARB-X is Accelerating Antibacterial Innovation
https://www.medicalcountermeasures.gov/federal-initiatives/public-meetings-and-conferences/barda-industry-day-2017.aspx
Next Generation Antibiotic Workshop: Transforming Discovery
UK Catapult Conference:
Next Generation Antibiotic Workshop: Transforming Discovery, London